Drug Shortage Report for SANDOZ FESOTERODINE FUMARATE
Report ID | 175986 |
Drug Identification Number | 02521768 |
Brand name | SANDOZ FESOTERODINE FUMARATE |
Common or Proper name | FESOTERODINE FUMARATE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | FESOTERODINE FUMARATE |
Strength(s) | 4MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 30PRT |
ATC code | G04BD |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-11-23 |
Estimated end date | 2022-12-09 |
Actual end date | 2022-12-14 |
Shortage status | Resolved |
Updated date | 2022-12-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-12-28 | French | Compare |
v3 | 2022-12-28 | English | Compare |
v2 | 2022-11-28 | French | Compare |
v1 | 2022-11-28 | English | Compare |
Showing 1 to 4 of 4